Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by ¹⁸F-FDG PET/CT.

IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Molecular Imaging and Radionuclide Therapy Pub Date : 2026-02-03 Epub Date: 2025-11-11 DOI:10.4274/mirt.galenos.2025.54036

Nur Aydınbelge Dizdar, Ebru Tatcı, Derya Çayır, Özlem Özmen

{"title":"Isolated Unilateral Ovarian Metastasis from Breast Cancer Demonstrated by 18F-FDG PET/CT.","authors":"Nur Aydınbelge Dizdar, Ebru Tatcı, Derya Çayır, Özlem Özmen","doi":"10.4274/mirt.galenos.2025.54036","DOIUrl":null,"url":null,"abstract":"A 49-year-old premenopausal woman with a history of left modified radical mastectomy and axillary lymph node dissection for invasive lobular carcinoma three years ago, underwent 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) due to gradually increasing CA15-9 and CEA levels during routine follow-up. Compared with previous 18F-FDG PET/CT images, the left ovary in the current images showed increased size and radiotracer uptake. Subsequently, total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed, and histopathological evaluation confirmed unilateral metastasis in the left ovary due to primary breast cancer. Although rare, possible isolated ovarian metastasis should be considered in patients with breast cancer who have increased size and radiotracer uptake in ovarian tissue on follow-up 18F-FDG PET/CT scans.","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":" ","pages":"55-57"},"PeriodicalIF":0.9000,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12869102/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Molecular Imaging and Radionuclide Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4274/mirt.galenos.2025.54036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/11/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

A 49-year-old premenopausal woman with a history of left modified radical mastectomy and axillary lymph node dissection for invasive lobular carcinoma three years ago, underwent ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) due to gradually increasing CA15-9 and CEA levels during routine follow-up. Compared with previous ¹⁸F-FDG PET/CT images, the left ovary in the current images showed increased size and radiotracer uptake. Subsequently, total abdominal hysterectomy and bilateral salpingo-oophorectomy were performed, and histopathological evaluation confirmed unilateral metastasis in the left ovary due to primary breast cancer. Although rare, possible isolated ovarian metastasis should be considered in patients with breast cancer who have increased size and radiotracer uptake in ovarian tissue on follow-up ¹⁸F-FDG PET/CT scans.

Abstract Image

查看原文本刊更多论文

18F-FDG PET/CT显示乳腺癌单侧卵巢转移。

一位49岁的绝经前女性，三年前因浸润性小叶癌行左侧改良根治术和腋窝淋巴结清扫术，由于常规随访期间CA15-9和CEA水平逐渐升高，她接受了18f -氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描（18F-FDG PET/CT）。与先前的18F-FDG PET/CT图像相比，当前图像显示左侧卵巢尺寸增大，放射性示踪剂摄取增加。随后行腹腔全子宫切除术和双侧输卵管卵巢切除术，组织病理学检查证实原发性乳腺癌所致左侧卵巢单侧转移。虽然罕见，但在随访的18F-FDG PET/CT扫描中发现卵巢组织体积增大和放射性示踪剂摄取增加的乳腺癌患者，应考虑可能存在孤立性卵巢转移。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Molecular Imaging and Radionuclide Therapy RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-

CiteScore

1.30

自引率

0.00%

发文量

期刊介绍： Molecular Imaging and Radionuclide Therapy (Mol Imaging Radionucl Ther, MIRT) is publishes original research articles, invited reviews, editorials, short communications, letters, consensus statements, guidelines and case reports with a literature review on the topic, in the field of molecular imaging, multimodality imaging, nuclear medicine, radionuclide therapy, radiopharmacy, medical physics, dosimetry and radiobiology.